Trials / Conditions / Persistent Pulmonary Hypertension of Newborn

Persistent Pulmonary Hypertension of Newborn

8 registered clinical trials studyying Persistent Pulmonary Hypertension of Newborn — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utili NCT06499363	Ferrer Internacional S.A.	—
Recruiting	Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn NCT04898114	Sohag University	Phase 1 / Phase 2
Withdrawn	Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure NCT01891500	University of Florida	Phase 4
Completed	Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns NCT01757782	Sir Takhtasinhji General Hospital	Phase 4
Unknown	Nitro Oxide Inhalation Continued With Sildenafil on Neonatal Persistent Pulmonary Hypertension NCT01373749	Third Military Medical University	N/A
Withdrawn	Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients NCT00981591	Seattle Children's Hospital	Phase 1 / Phase 2
Terminated	N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension NCT00443859	Christiana Care Health Services	—
Completed	Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study NCT01203423	NICHD Neonatal Research Network	—